Publications
- Association of Pax5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder2006 | Second Faculty of Medicine
- The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlation with pathological findings and clinical outcome2003 | Second Faculty of Medicine
- Methylation changes in promoter and enhancer regions of the WT1 gene in Wilms'tumours2001 | Second Faculty of Medicine
- A method for detection of germinal mutations in the p53 tumor suppressor gene1996 | Second Faculty of Medicine
- Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer2016 | First Faculty of Medicine, Second Faculty of Medicine
- MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection2016 | First Faculty of Medicine, Second Faculty of Medicine
- Comparison of MicroRNA Content in Plasma and Urine Indicates the Existence of a Transrenal Passage of Selected MicroRNAs2016 | First Faculty of Medicine, Second Faculty of Medicine
- Prediction of recurrence in low and intermediate risk non-muscle invasive bladder cancer by real-time quantitative PCR analysis: cDNA microarray results2013 | First Faculty of Medicine, Second Faculty of Medicine
- Expression of BCL-2 and BAX-1 genes in the tissue of Ta, T1 urothelial carcinoma and their prognostic value2013 | First Faculty of Medicine, Second Faculty of Medicine
- Expression of SHB in prostate cancer tissue: its role in the diagnostics and prognostics2012 | Second Faculty of Medicine
Loading network view...